Logo
x

Search

Subscribe Now

 Regulatory

PharmaShots Weekly Snapshots (February 24, 2025 – February 28, 2025)

PharmaShots Weekly Snapshots (February 24, 2025 – February 28, 2025)

  • February 28, 2025
ALK Reports US FDA Approval of Odactra to Treat Children with House Dust Mite Allergy

ALK Reports US FDA Approval of Odactra to Treat Children with House Dust Mite Allergy

  • February 28, 2025
Fapon Biopharma Reports the US FDA Approval of IND Application for FP008 to Treat Solid Tumors

Fapon Biopharma Reports the US FDA Approval of IND Application for FP008 to Treat Solid Tumors

  • February 28, 2025
The CHMP Adopts Positive Opinion for AbbVie’s Rinvoq (Upadacitinib) to Treat Giant Cell Arteritis in Adults

The CHMP Adopts Positive Opinion for AbbVie’s Rinvoq (Upadacitinib) to Treat Giant Cell Arteritis in Adults

  • February 28, 2025
GRIN Therapeutics Reports the US FDA’s Breakthrough Therapy Designation for Radiprodil to Treat Seizures in GRIN-Related Neurodevelopmental Disorder

GRIN Therapeutics Reports the US FDA’s Breakthrough Therapy Designation for Radiprodil to Treat Seizures in GRIN-Related Neurodeve...

  • February 27, 2025
Ardelyx Reports China’s NMPA Approval of Tenapanor for Hyperphosphatemia in Patients

Ardelyx Reports China’s NMPA Approval of Tenapanor for Hyperphosphatemia in Patients

  • February 27, 2025
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2025 PharmaShots - All Rights Reserved.